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ABSTRACT To determine the importance of electrostatic interactions for agonist binding to the nicotinic acetylcholine
receptor (AChR), we examined the affinity of the fluorescent agonist dansyl-C6-choline for the AChR. Increasing ionic strength
decreased the binding affinity in a noncompetitive manner and increased the Hill coefficient of binding. Small cations did not
compete directly for dansyl-C6-choline binding. The sensitivity to ionic strength was reduced in the presence of proadifen,
a noncompetitive antagonist that desensitizes the receptor. Moreover, at low ionic strength, the dansyl-C6-choline affinities
were similar in the absence or presence of proadifen, a result consistent with the receptor being desensitized at low ionic
strength. Similar ionic strength effects were observed for the binding of the noncompetitive antagonist [3H]ethidium when
examined in the presence and absence of agonist to desensitize the AChR. Therefore, ionic strength modulates binding
affinity through at least two mechanisms: by influencing the conformation of the AChR and by electrostatic effects at the
binding sites. The results show that charge-charge interactions regulate the desensitization of the receptor. Analysis of
dansyl-C6-choline binding to the desensitized conformation using the Debye-Hu¨ckel equation was consistent with the
presence of five to nine negative charges within 20 Å of the acetylcholine binding sites.
INTRODUCTION
The nicotinic acetylcholine receptor (AChR) is a cation-
selective, ligand-gated ion channel found at the vertebrate
neuromuscular junction and in the electric organ of Torpedo
californica. It is a transmembrane pentamer composed of
four different subunits assembled with a stoichiometry
2 around an axis of pseudosymmetry perpendicular to
the plane of the membrane (Barrantes, 1998; Devillers-
Thiery et al., 1993; Hucho et al., 1996). The AChR pen-
tamer contains two activating binding sites for acetylcholine
(ACh); one site is at the interface between the first  subunit
and the  subunit, and the second site is between the second
 subunit and the  subunit (Blount and Merlie, 1989;
Pedersen and Cohen, 1990). The binding of two agonist
molecules to the ACh sites induces the channel to open.
Prolonged exposure to agonist results in the desensitization
of the receptor into a nonconductive state. The AChR also
contains a high affinity binding site for noncompetitive
antagonists (NCA); the site is within the ion channel, which
is located at the axis of the pseudosymmetry in the trans-
membrane region. NCAs appear to inhibit channel activity
by steric block of ion flux (Neher and Steinbach, 1978).
At physiological conditions the AChR exists in equilib-
rium between the resting conformation and the desensitized
conformation. Because the conformational state of the
AChR influences ligand binding, binding of agonists to
ACh sites or NCAs to the channel site can be modeled by
cyclic schemes (Schemes I and II) as shown below (Katz
and Thesleff, 1957; Ochoa et al., 1989). Scheme I shows a
single binding site, which describes the binding of NCAs.
For ligands that bind two sites, such as agonists, a similar
scheme (II) with two binding steps applies. KR and KD
represent the microscopic dissociation constants for the
resting and desensitized conformations, respectively; M is
the allosteric constant, which equals the ratio of concentra-
tions of desensitized to resting AChR in the absence of
ligand (L).
The conformational equilibrium is regulated by binding of
agonists and by the binding of NCAs (Ochoa et al., 1989).
NCAs may influence the conformation of the AChR by
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stabilizing either the resting or the desensitized conforma-
tion, depending on the exact ligand. For example, proadifen,
phencyclidine, and ethidium bromide (EB) significantly in-
crease agonist affinity because they promote the desensi-
tized conformation (Cohen et al., 1986; Krodel et al., 1979).
Reciprocally, the presence of an agonist such as acetylcho-
line or carbamylcholine (Carb) increases the binding affin-
ity of desensitizing NCAs for the channel site (Changeux et
al., 1984; Walker et al., 1982).
The positively charged character of agonists and compet-
itive antagonists suggests that electrostatic interactions may
play an important role for ligand binding and the receptor’s
function; at low ionic strength the binding affinity of d-
tubocurarine to AChR is stronger (Neubig and Cohen,
1979) and the rate of -bungarotoxin binding increases
dramatically (Schmidt and Raftery, 1974). However, vari-
ous labeling studies have identified primarily aromatic
amino acid residues that contribute to ACh binding, includ-
ing the following residues in the -subunit: Tyr-93, Trp-
149, Tyr-190, and Tyr-198 (Devillers-Thiery et al.,
1993). The role of these residues in binding is consistent
with the hypothesis that the cationic moiety associated with
cholinergic ligands is stabilized predominantly by interac-
tions with aromatic ring -electrons (Dougherty, 1996;
Zhong et al., 1998).
Stabilization of the cation by formation of a charge pair
or through electrostatic interactions, however, has not been
excluded. A substantial electrical potential (80 mV) was
found by the relative reactivity of variously charged meth-
anethiosulfonate derivatives with Cys-192/193, suggesting
the presence of several negative charges near the binding
sites (Stauffer and Karlin, 1994). In contrast, power satura-
tion EPR of spin-labeled ligands yielded a smaller electro-
static potential of 15 mV (Addona et al., 1997). Several
candidate negative charges that affect binding were deter-
mined by cross-linking studies (Asp-180 (Czajkowski and
Karlin, 1995; Martin et al., 1996)) and site-directed mu-
tagenesis (Asp-152 (Sugiyama et al., 1996)). These resi-
dues may constitute a counter-charge or provide electro-
static stabilization for the cholinergic cation.
Despite the substantial data supporting a mechanism of
binding that included electrostatic attraction, it remains un-
clear whether such stabilization occurs by salt-bridge for-
mation, long-range attraction, or both. The increasing evi-
dence for aromatic -electron stabilization of the organic
cation does not exclude the presence of electrostatic stabi-
lization (e.g., see Tan et al., 1993). Nonetheless, the number
of charged groups and their distribution near the ACh sites
is not known, nor has any relevance of electrostatic inter-
actions to binding at physiological ionic strength been
clearly demonstrated.
In the present study we measured the ionic strength
dependence of the binding affinity of a fluorescent analog of
acetylcholine dansyl-C6-choline (Dns-C6-Cho) (Heidmann
et al., 1983) to determine the significance of electrostatic
interactions. The data suggest a broad distribution of five to
nine negative charges near the agonist binding sites. In
addition, we found that the AChR is relatively desensitized
at low ionic strength; at high ionic strength the resting state
is relatively stabilized. A similar conclusion was reached by
examining the ionic strength dependence of the affinity of
[3H]EB, an NCA. The ionic strength effect on the confor-
mational equilibrium found by both agonist and NCA bind-
ing suggests that charge-charge interactions regulate the
desensitization of the receptor.
MATERIALS AND METHODS
Materials
EB, carbamylcholine chloride (Carb), sodium dodecyl sulfate (SDS), dan-
syl chloride, and phencyclidine hydrochloride (PCP) were purchased from
Sigma Chemical Co. (St. Louis, MO); proadifen was from Research
Biochemicals International (Natick, MA); Hepes was from Boehringer-
Mannheim (Indianapolis, IN); NaCl, LiCl, and KCl were from Fisher
Science (Pittsburgh, PA); RbCl was from EM Science (Gibbstown, NJ);
and CsCl was from Amresco (Solon, OH).
AChR-rich membranes were isolated from Torpedo californica electric
organ (Marinus Inc., Long Beach, CA or Aquatic Research Consultants,
San Pedro, CA) by differential sucrose ultracentrifugation as described
previously (Pedersen et al., 1986; Sobel et al., 1977). Purified membranes
typically contained 1–2 nmol of ACh sites/mg of protein as measured by
binding of [3H]ACh (Pedersen, 1995). Membranes were stored in 37%
sucrose/0.02% NaN3 at 80°C under argon. The AChR-rich membranes
were treated with diisopropylfluorophosphonate (Aldrich Chemical Co.,
Milwaukee, WI) to inactivate acetylcholinesterase immediately before
binding experiments with Dns-C6-Cho.
Dns-C6-Cho was synthesized from dansyl chloride and N-carbobenz-
oxy--aminocaproic acid (Bachem, King of Prussia, PA) using the proce-
dures in the literature (Waksman et al., 1976). [3H]EB (1.15 Ci/mmol) was
obtained as described previously (Lurtz et al., 1997).
Dns-C6-Cho fluorescence binding assays
The interaction of Dns-C6-Cho with the AChR-rich membranes was mon-
itored under conditions of energy transfer from protein tryptophan(s),
which results in an 10-fold increase in fluorescence intensity at the
maximal emission wavelength (em  557 nm) (Waksman et al., 1976).
Fluorescence data were collected on an SLM 8000C fluorometer. The
excitation light from a 350 W xenon short arc lamp was filtered with a UV
pass filter (Oriel 59152). Each sample was excited at 292 nm with a 2.0 nm
bandwidth. To improve the signal, the emission light was collected directly
by mounting the photomultiplier on the emission window without going
through the monochromator and was only filtered through a 495-nm cut-on
filter (Oriel 59492).
Dns-C6-Cho binding assays were carried out in 20 mM Hepes (pH 
7.0) at various ionic strengths that were controlled by the NaCl concen-
tration. Binding isotherms were measured by titration of AChR-rich mem-
brane suspensions with a concentrated Dns-C6-Cho solution. Excess Carb
(1 mM) was used to define the nonspecific fluorescence of Dns-C6-Cho in
samples titrated in parallel. Binding measurements in the presence of
proadifen were also carried out in parallel. To observe the effects of salt in
more detail we chose one set of concentrations of Dns-C6-Cho and AChR
that were kept constant, and assayed separate samples that contained
varying salt concentrations (NaCl, LiCl, KCl, RbCl, and CsCl) by mea-
suring fluorescence of Dns-C6-Cho, as described above.
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[3H]EB binding assays
[3H]EB binding assays were performed by centrifugation as described
previously (Pedersen, 1995). Both bound and free [3H]EB were measured
by counting the pellet and supernatant for each sample. To observe the
effect of ionic strength on EB binding over a broad range we picked a
single concentration of [3H]EB and AChR, and varied the concentration of
NaCl. Nonspecific binding was determined by including excess of the
inhibitor PCP (0.5 mM).
Binding data analysis
To define the dissociation constant, K, and the Hill coefficient, n, Dns-C6-
Cho binding isotherms were fitted with the Hill equation (Eq. 1) by
nonlinear regression (SigmaPlot vs. 2, Jandel Scientific).
FL	
C  R0
1
 K/Ln
(1)
where [L] is the Dns-C6-Cho concentration, FL is the fluorescence inten-
sity after subtraction of the corresponding nonspecific binding, R0 is the
total binding site concentration, and C is the proportionality constant of the
fluorescence intensity to bound ligand concentration (FL  C  [RL]). C
was determined as a freely fit parameter in the nonlinear regression and
was obtained simultaneously with K and n. In cases where the observed
Hill coefficient n was near 1, as in the presence of proadifen, the binding
data were sometimes fit with the simple binding equation (i.e., Eq. 1 with
n  1).
The data were usually analyzed in terms of the total Dns-C6-Cho
concentration added. In some cases the free Dns-C6-Cho differed substan-
tially from the added concentration because of binding to the AChR,
particularly in the cases of high-affinity binding at low ionic strength or in
the presence of proadifen. To avoid error in the determination of the K
value, such data were fit with Eq. 2, which explicitly accounts for bound
ligand. L0 is the total ligand concentration added.
FL	
C
2
K
 R0
 L0 K
 R0
 L02 4R0L0 (2)
Eq. 2 was used only in situations where the Hill coefficient was 1. This
improved the accuracy for the determination of K at conditions of high
affinity. In no case did the values determined by Eqs. 1 and 2 differ by
more than twofold, and usually 	20%.
The binding data obtained at single concentrations of Dns-C6-Cho and
AChR were analyzed to calculate the dissociation constants using Eq. 3,
which was derived from the Hill equation:
K	 C  R0FL  1
1/n
 L0 FLC  (3)
For these experiments, C was experimentally determined from a calibration
curve of bound Dns-C6-Cho fluorescence versus Dns-C6-Cho concentra-
tion. The calibration curve was measured with a large excess of AChR over
Dns-C6-Cho under conditions where nearly all the Dns-C6-Cho was bound
to the receptor.
The dissociation constant of [3H]EB was calculated using the following
equation:
K	 R0 LBLF/LB (4)
where R0 is the total AChR concentration and LF and LB are the concen-
trations of free ligand and specific bound ligand, respectively; these values
were obtained by scintillation counting of bound and free [3H]EB.
Effective charges at the binding site
To calculate the effective charges at the binding sites the ionic strength
dependence of the dissociation constant could be fitted with an equation
derived from the Debye-Hu¨ckel theory (Nolte et al., 1980). The Debye-
Hu¨ckel limiting law treats the charged species (i) as a point charge (zie) and
gives the activity coefficient (i) as a function of ionic strength (I) in a
dilute solution:
log i	A  zi
2  I (5)
Considering the size of the charged species, the Debye-Hu¨ckel equation
can be modified to include the effective radius of the charge (r) (Levine,
1988, pp. 281–283):
log i	
A  zi
2  I
1
 r  B  I (6)
where A and B are thermodynamic constants (A 0.509, B 3.291 nm1 
M1/2 at 298 K in water). For a binding reaction between two charged
species, R (with a charge zR) and L (with a charge zL), the thermodynamic
dissociation constant K0 depends on the activity, ai, of each species:
K0	
aR  aL
aRL
	
R  L
RL

R  L
RL
	 K 
R  L
RL
(7)
The charge of RL, zRL, equals zR 
 zL; further substituting Eq. 6 into Eq.
7, the dependence of the concentration dissociation constant K on ionic
strength is given by Eq. 8:
log K	 log K0
2  A  zR  zL  I
1
 r  B  I (8)
Assuming the known ligand charge (zL), the effective receptor charge, zR,
and the charge distribution, r, can be obtained by fitting data of dissociation
constant versus ionic strength with Eq. 8. Nolte et al. (1980) used this
equation to analyze the effective charge distribution near the reactive site
of acetylcholinesterase.
Determination of the allosteric constant, M
Under the cyclic scheme of single site binding shown in the introduction
(Scheme I), the fractional occupancy of the binding sites (Y) can be
expressed in terms of the microscopic dissociation constants for the resting
state (KR) and for the desensitized state (KD), and M.
Y	
RL
 DL
R
 RL
 D
 DL
	
L
KR

M 
L
KD
1

L
KR

M
M 
L
KD
(9)
When 50% of the sites are bound with ligand (Y  0.5), the ligand
concentration [L] equals the apparent dissociation constant (Kapp). From
Eq. 9, M is given by Eq. 10:
M	
KD  KR Kapp
KR  Kapp KD
(10)
M
KD
Kapp KD
(11)
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When KR  KD and KR  Kapp, M is closely approximated by Eq. 11.
This approximation is generally valid for cholinergic ligands that bind with
substantially lower affinity to the native resting state (e.g., KR 5–500 M
for acetylcholine (Sine et al., 1990)). Kapp and KD are measured in the
absence and presence of a desensitizing allosteric ligand, respectively. For
ligand binding to two sites with equal affinity, as in Scheme II (KR1 
KR2 KR for the R-state, KD1 KD2 KD for the D-state), the expression
for M can be similarly derived.
M	
KD1  KD2  KR1  KR2 Kapp
2 
KR1  KR2  Kapp
2  KD1  KD2
	
KD
2  KR
2  Kapp
2 
KR
2  Kapp
2  KD
2 

KD
2
Kapp
2  KD
2 (12)
RESULTS
To determine the importance of ionic interactions for ago-
nist binding to the AChR we examined the binding of the
fluorescent agonist Dns-C6-Cho at various ionic strengths.
In preliminary experiments we had observed that Dns-C6-
Cho binding was enhanced at low ionic strength and was no
longer affected by the presence of a desensitizing NCA.
Because the conformational state of the AChR will influ-
ence agonist binding, it was necessary to distinguish the
relative influence of ionic strength changes on the confor-
mational equilibrium versus pure ionic interactions on the
binding of Dns-C6-Cho.
Proadifen fails to modulate agonist binding at
low ionic strength
Proadifen desensitizes the receptor by binding to the high-
affinity NCA site of the AChR (Krodel et al., 1979). The
extent of desensitization was observed by changes in affin-
ity of Dns-C6-Cho, as monitored by changes in fluorescence
intensity. We measured the change in Dns-C6-Cho binding
to the AChR upon titration with increasing concentrations
of proadifen at different NaCl concentrations. Shown in Fig.
1 are the data at 0, 50, and 250 mM NaCl. The lower curve
(Œ) shows the effect of proadifen in 250 mM NaCl, which
is near the physiological salt concentration; the fluorescence
intensity of bound Dns-C6-Cho increases with proadifen at
concentrations near 2 M. The increase can be fit to a
simple, single-site binding equation, indicating that the de-
sensitization and the increased binding affinity of Dns-C6-
Cho are caused by the noncompetitive binding of proadifen.
At higher concentrations (100 M), proadifen decreases
the Dns-C6-Cho binding, an effect likely due to direct,
competitive binding to the ACh sites.
At low ionic strength ([NaCl]  0), Dns-C6-Cho affinity
was much higher, as observed by the stronger fluorescent
signal (F). The fluorescence was unaffected by proadifen
until concentrations that decrease binding were reached at
10 M. In 50 mM NaCl the effects were intermediate; the
affinity increase due to proadifen was smaller and occurred
at lower concentrations than in 250 mM NaCl. The intrinsic
affinity of proadifen appeared to increase at lower ionic
strength, whereas the allosteric effect on agonist binding
was gradually lost: an increase in potency and a loss of
efficacy. The curves also indicated the optimum concentra-
tions of proadifen for later experiments that provide maxi-
mal increase in agonist binding without interference from
binding to the ACh sites (i.e., 1–10 M).
Dns-C6-Cho affinity measured by
binding isotherms
Binding isotherms of Dns-C6-Cho were measured at vari-
ous concentrations of NaCl by titration of AChR with
Dns-C6-Cho in the absence and presence of proadifen. The
typical isotherms of specific binding at 0 mM and 250 mM
NaCl are displayed in Fig. 2. Panel A shows binding of
Dns-C6-Cho to AChR-rich vesicles at 250 mM NaCl, near
physiological ionic strength. The solid circles show sigmoid
binding that was fit to the Hill equation (Eq. 1), as indicated
by the curves. In the presence of proadifen the data dis-
played hyperbolic concentration dependence that was well
fit by the simple binding equation (Eq. 1 with n  1). The
Kapp was decreased relative to binding in the absence of
proadifen with apparent loss of cooperativity, an observa-
tion consistent with proadifen increasing binding affinity by
desensitizing the AChR. In contrast, at low ionic strength
(Fig. 2 B), binding was similar in affinity and noncoopera-
tive, regardless of the presence of proadifen. The inset in
Fig. 2 shows the original total and nonspecific fluorescence
data that correspond to the solid circles in Fig. 2 B.
To determine the NaCl concentration range that affects
Dns-C6-Cho affinity, binding isotherms were determined in
the same manner as described in Fig. 2, with NaCl concen-
trations that varied from 0 to 1 M. The data were fitted with
FIGURE 1 The proadifen dependence of specifically bound Dns-C6-
Cho fluorescence at various ionic strengths. AChR-rich membranes (5 nM
ACh sites) were incubated with Dns-C6-Cho (6 nM) in 20 mM Hepes (pH
7.0) plus NaCl (F, 0 mM; f, 50 mM; Œ, 250 mM) and the indicated
concentrations of proadifen for 1 h. Fluorescence measurements were
carried out as described in Materials and Methods. The plots show specific
fluorescence, the difference between binding in the presence and absence
of 1 mM carbamylcholine.
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the Hill equation to calculate the dissociation constant, Kapp,
and Hill coefficient, n. In the cases where the Hill coeffi-
cient was near 1, the Kapp was recalculated using Eq. 2. The
results are plotted in Fig. 3. Fig. 3 A compares the ionic
strength dependence of the dissociation constant in the
absence and presence of proadifen. At low ionic strength,
the Kapp values are similar in the absence or presence of
proadifen. However, as the NaCl concentration increases,
the Kapp values diverge until the difference approaches that
normally observed at physiological ionic strength.
In the presence of proadifen the corresponding Hill co-
efficients (n) shown in Fig. 3 B are close to 1, and display
no ionic strength dependence. The titration binding data in
the presence of proadifen at any ionic strength were well-fit
with the simple binding equation, showing no cooperativity.
Likewise, in the absence of proadifen at low ionic strength,
n reduces to 1 (Fig. 3 B). However, in the absence of
proadifen at high ionic strengths the binding data were
best-fit with the Hill equation, and the Hill coefficient
approached 1.6. The predominant change in affinity oc-
curred in the range of 0–200 mM NaCl.
To determine the ionic strength dependence of the bind-
ing affinity in more detail we needed more data points than
could be obtained reasonably by carrying out full binding
isotherms at each ionic strength. Therefore, we chose to
examine many NaCl concentrations at a single concentra-
tion of AChR and of Dns-C6-Cho. Fig. 4 A displays the
fluorescence intensity of the specific bound Dns-C6-Cho in
a suspension of 5 nm ACh binding sites and 6 nM Dns-C6-
Cho as a function of ionic strength of the solution, in the
absence (F) and presence (E) of proadifen. Using a cali-
bration curve generated in the same experiment, the actual
concentration of bound Dns-C6-Cho was determined from
the observed fluorescence intensity. By obtaining the bound
concentration of Dns-C6-Cho in this manner, the Kapp at
each NaCl concentration was calculated using Eq. 3, as
described in Materials and Methods. The corresponding
dissociation constants are displayed in Fig. 4 B. The results
are consistent with those obtained from the binding iso-
therms (Fig. 3 A); in both cases the binding decreased with
increasing ionic strength with smaller changes in the pres-
ence of proadifen. The largest changes in each curve oc-
curred at NaCl concentrations 	100 mM.
Group IA cations inhibit agonist binding
To test whether the effect of NaCl concentration on the
binding affinity was due to specific interactions between
FIGURE 2 Dns-C6-Cho binding to the AChR in low and high ionic
strength. (A) AChR-rich vesicles (5 nM ACh sites) were incubated in 20
mM Hepes/250 mM NaCl in the presence or absence of 1 mM Carb.
Fluorescence was measured while titrating the vesicle suspension with
Dns-C6-Cho, as described in Materials and Methods. Specific binding was
determined by subtraction of data obtained in the presence of Carb. The
specific binding is shown for data obtained in the absence (F) or presence
(E) of 10 M proadifen. (B) AChR-rich vesicles (0.5 nM ACh sites) were
titrated in 20 mM Hepes and the binding isotherms determined as described
for (A). For both panels, the specific fluorescence intensity was normalized
to the ACh site concentrations and the data fitted with the Hill equation
(solid curves). The inset in (B) shows the uncorrected fluorescence titration
data obtained in the absence (E) and presence () of 1 mM Carb in 20 mM
Hepes. The following Kapp values were determined for the presence and
absence of proadifen, respectively: (A) K  7.9 nM (n  1.1) and 27 nM
(n  1.6); (B) K  1.35 nM (n  1.1) and 1.27 nM (n  1.1).
FIGURE 3 The Kapp and the Hill coefficient of Dns-C6-Cho binding are
affected by ionic strength. Dns-C6-Cho binding isotherms were measured
by titration of Dns-C6-Cho into an AChR-rich membrane suspension, as
described in Fig. 2 and in Materials and Methods. AChR-rich membranes
(0.5 nM at [NaCl] 0 mM; 1 or 5 nM at [NaCl] 50 mM; 5 nM at higher
ionic strengths) were pre-incubated with indicated concentrations of NaCl
without proadifen (F) or with proadifen (E, 1 M at 0 mM NaCl, 10 M
for all others) in 20 mM Hepes (pH 7.0) for 1 h. Titrations were carried out
by addition of concentrated Dns-C6-Cho solutions; nonspecific binding
was determined in parallel titrations carried out in the presence of 1 mM
Carb. After subtraction of nonspecific binding, the data were fit to the Hill
equation, Eq. 1. (A) Dissociation constant, Kapp, and (B) Hill coefficient.
Error bars are the standard deviations of 4–20 independent determinations.
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Na
 and the receptor or due to nonspecific electrostatic
effects, salts other than NaCl were also used to control the
ionic strength. Fig. 5 A shows the results using salts of the
group IA monovalent cations: LiCl, NaCl, KCl, RbCl, and
CsCl. All the monovalent cations tested reduce the binding
of Dns-C6-Cho similarly, but reach distinct levels of bind-
ing at higher ionic strengths. The corresponding binding
data carried out in 10 M proadifen are shown in Fig. 5 B.
The binding was likewise reduced by increasing salt con-
centrations, and the various ions differed in the extent of
inhibition observed. Except for Cs
, the binding data tend
toward minimum plateau values at concentrations of salt up
to 1 M (data not shown; the range in Fig. 5 goes only to 0.25
M). Nonetheless, the cations in Fig. 5 clearly display ion-
specific effects on the affinity. The rank order of the extent
of inhibition of binding (Fig. 5 A) is the same as the periodic
table, and therefore correlates with the cation size or, in-
versely, with dehydration energy.
[3H]Ethidium binding
The data shown above clearly reveal ionic effects on agonist
affinity and that increased ionic strength facilitates proad-
ifen effects on agonist affinity. These changes, therefore,
suggest that ionic strength affects the conformational equi-
librium of the AChR. A second method to test this notion is
to examine the reciprocal effect of agonist upon the binding
of the desensitizing NCA, EB. EB is suitable for this mea-
surement because it is strongly sensitive to desensitization
and affinity can be measured by radioligand binding (Herz
et al., 1987; Lurtz et al., 1997; Pedersen, 1995). EB binding
was examined at various ionic strengths in the presence and
absence of the agonist Carb. Fig. 6 A shows the ratio of
specifically bound [3H]EB to free [3H]EB, a value that is
proportional to the affinity under these conditions, as a
function of ionic strength, while the receptor and total EB
concentrations were kept fixed. The dissociation constants
for EB were calculated using Eq. 4 (Fig. 6 B). Compare this
figure with Figs. 3 A and 4 B: there exists remarkable
similarity between the binding of Dns-C6-Cho to the ACh
site and the binding of [3H]EB to the channel site. The
dissociation constant in both cases increases with ionic
strength. At high ionic strengths the dissociation constants
in the absence of a desensitizing ligand were much higher
FIGURE 4 The ionic strength dependence of Dns-C6-Cho binding. (A)
AChR-rich membranes (5 nM ACh sites) were incubated with 6 nM
Dns-C6-Cho, with (E) or without (F) proadifen (10 M), and with various
concentrations of NaCl in 20 mM Hepes (pH 7.0) to give the indicated
ionic strength. After 1 h equilibration, Dns-C6-Cho fluorescence was
measured as described in Materials and Methods. Specific fluorescence
was plotted from the difference in the presence and absence of 1 mM Carb.
(B) Kapp values without proadifen (F) and with proadifen (E), as calculated
from the data in (A). To determine the concentration of bound Dns-C6-Cho
from the fluorescence data, the proportionality constant for bound fluores-
cence, C, was determined by titration of Dns-C6-Cho into excess AChR
(see Materials and Methods). From the value of bound Dns-C6-Cho con-
centration, the known concentrations of ACh binding sites, and the added
Dns-C6-Cho, the Kapp for binding was calculated for each ionic strength
using Eq. 3.
FIGURE 5 Monovalent ions affect Dns-C6-Cho bind-
ing similarly. Dns-C6-Cho binding to the ACh sites was
determined in varying concentrations of the group IA
chloride salts. AChR-rich membranes (5 nM ACh sites)
were incubated with Dns-C6-Cho (6 nM) and the indi-
cated concentration of the salts (E, CsCl; , RbCl; ‚,
KCl; ƒ, NaCl; , LiCl) in 20 mM Hepes (pH 7.0) for
1 h. Fluorescence intensity was then measured as de-
scribed in Materials and Methods, in the presence and
absence of 1 mM Carb; the specific fluorescence was
determined from the difference. (A) No proadifen; (B) 10
M proadifen.
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than that in its presence. In both cases the Kapp values
converge at low ionic strength.
The dependence of the allosteric constant M on
ionic strength
The conformational equilibrium of the AChR is described
by the ratio of concentrations of desensitized to resting
receptor (M [D]/[R]; see Schemes I and II). This allosteric
constant, M, can be estimated from the change in Kapp
caused by addition of an allosteric desensitizing ligand
using Eq. 11, given in Materials and Methods.
The allosteric constant was calculated as a function of
ionic strength from the Dns-C6-Cho binding data shown in
Figs. 3 A and 4 B, and from the EB binding data shown in
Fig. 6. For the Dns-C6-Cho binding data M was calculated
assuming either the one site model (Scheme I; Fig. 7 A,
circles) or the two-site model (Scheme II; Fig. 7 A,
squares). The two-site model yields substantially lower
values for M. The values determined by EB binding agree
with those determined by calculating M from the single-site
model for Dns-C6-Cho binding. The M value increases
30–100-fold as ionic strength is decreased, but it is unclear
whether the upper limit of M has been reached at the lowest
ionic strengths tested.
The EB and Dns-C6-Cho calculations in Fig. 7 A were
derived from data obtained by varying the NaCl concentra-
tion. Because other monovalent cations affect binding to
various extents (Fig. 5), we also determined the value for M
in each of the group IA cations at a single high ionic
strength (250 mM). Binding isotherms were carried out in
buffer with each of the salts, in the presence and absence of
proadifen, and the value of M calculated according to Eq.
11, corresponding to Scheme I. As shown in Fig. 7 B, the
resultant values were similar; this demonstrates that the
value of M does not depend on the type of monovalent
cation used. This result further suggests that the distinct
effects of salts on the extent of binding shown in Fig. 5 were
due to differential effects of salts on the binding of Dns-
C6-Cho itself rather than effects on the conformational
equilibrium.
An alternative method for measuring desensitized AChR
is by determining the percentage of AChR that initially
binds agonist with high affinity, before the slow onset of
agonist-induced desensitization (Boyd and Cohen, 1980). In
preliminary experiments we examined the binding kinetics
of Dns-C6-Cho using stopped-flow fluorescence, and found
that in the physiological buffer HTPS20% of the receptor
was in a high-affinity state before the onset of slow, Dns-
C6-Cho-induced desensitization (data not shown). This cor-
responds to a value for M of 0.25. Parallel experiments
carried out in the presence of proadifen were consistent with
desensitization of 90% of the AChR, corresponding to an
M value of 10. These data reflect a somewhat more direct
method for determining M and yield values consistent with
those obtained from the EB binding data and from analysis
of the Dns-C6-Cho binding data as analyzed with the single
binding site model (Scheme I and Eq. 11).
The change in M is 25–30 fold, as estimated from calcu-
lations of EB binding and the Dns-C6-Cho binding data
from the single-site model. When the two-site model is
used, the change in M approaches 100-fold. The 30- to
100-fold change in the allosteric constant represents a sig-
nificant change in the conformational equilibrium.
DISCUSSION AND CONCLUSIONS
The data presented above demonstrate that increasing ionic
strength lowers the affinity of agonists for the ACh binding
sites of the AChR, and further show that the change is
smaller in the presence of the desensitizing noncompetitive
antagonist, proadifen. The effect of salt on affinity, there-
fore, had two distinct components: a direct effect on the
binding affinity of agonists and a second effect mediated by
altering the conformational equilibrium between the desen-
sitized and resting states. At low ionic strength, cooperat-
ivity of agonist binding is lost and the ability of proadifen to
influence agonist affinity is lost. The observations are con-
sistent with preferential stabilization of the high-affinity,
desensitized conformation of the AChR at low ionic
FIGURE 6 The ionic strength dependence of ethidium binding to the
noncompetitive antagonist site of the AChR. AChR-rich membranes (100
g; 337 nM ACh sites) were incubated with [3H]EB (34 nM), with (E) or
without (F) Carb (1 mM), and indicated concentration of NaCl in 20 mM
Hepes (pH 7.0) for 1 h. Bound and free [3H]EB were then determined after
separation by centrifugation as described in Materials and Methods. The
data were corrected for nonspecific binding by including 0.5 mM PCP. (A)
The ratio of bound/free [3H]EB; (B) the dissociation constants in the
absence and presence of Carb calculated from the data in (A) according to
Eq. 4.
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strength. Below, we discuss separately these two effects of
ionic strength changes on affinity.
Desensitization of AChR at low ionic strength
The extent of desensitization at various ionic strengths,
expressed by the equilibrium constant, M, was calculated
from the Dns-C6-Cho binding data (Fig. 7) using Eq. 12,
which corresponds to the two-binding-site model (Scheme
II). However, it is unclear why these low M values differ
substantially from those observed by EB binding. The M
values determined from EB binding data agree with our
estimates of the desensitized population from rapid kinetic
measurements of pre-existing, high-affinity AChR (data not
shown), with published values for the extent of desensiti-
zation (Boyd and Cohen, 1984), and with a recent charac-
terization of Dns-C6-Cho binding (Raines and Krishnan,
1998, M  0.1). Perhaps coincidentally, when the Dns-C6-
Cho binding data were analyzed by the single-site binding
scheme (I), it yielded values consistent with the EB binding
data. The primary assumption made in these calculations
was that the microscopic binding constants for the resting
state conformation (KR) be significantly higher than the
observed binding constants (Kapp). This was true for Dns-
C6-Cho, where the lower K of the two binding steps to the
resting state (KR1) was estimated at 1 M (Raines and
Krishnan, 1998), a value 20-fold higher than the highest
Kapp we observed, and therefore not a significant source of
error in the calculation. We also considered models with
assumptions of widely differing KR values at each site (from
our measurements, the KD values are the same at each site)
or with varying fluorescence yield at each site. These more
elaborate two-site models yielded M values consistent
with the simple two-site model. Understanding the source
of this discrepancy in M will, therefore, require further
experimentation.
Despite the model-dependent discrepancy in the absolute
values of M, the results from both schemes indicate that the
receptor is relatively more desensitized at low ionic strength
and the resting-state population increases as ionic strength
increases. The measured change inM (30–100-fold) reflects
a minimum estimate because the lowest ionic strength tested
was 6 mM. These changes correspond to free energy
changes of 2 to 2.7 kcal/mol. Regardless of the model used,
this represents a significant shift of the conformational
equilibrium with ionic strength.
Various monovalent salts were tested for their effects on
affinity and the extent of desensitization was determined
using Eq. 10. It was found that desensitization was essen-
tially independent of the type of cation used (Fig. 7 B). This
suggests that the change in conformation induced by ionic
strength changes was due not to ion binding interactions, but
rather to electrostatic screening. That observation further
suggests that the effects can be interpreted in terms of
simple electrostatic repulsion or attraction.
A structural model for desensitization
The electrostatic screening that drives the conformational
change with ionic strength must be due to interactions of
surface charges with intervening solvent. If the charges
were buried or separated only by protein, the charge inter-
actions would not be expected to be moderated by ionic
strength changes. Interaction among charged surface resi-
FIGURE 7 The ionic strength dependence of the allosteric constant (M). (A) The value of M was calculated from Dns-C6-Cho binding data shown in
Fig. 4 B (F, f) and the summarized data from binding isotherms shown in Fig. 3 A (E, ). M was calculated using either the single-binding site model,
Eq. 11 (E, F), or the two-binding site model, Eq. 12 (, f), as described in Materials and Methods. M was also calculated from [3H]EB binding data (Fig.
6 A) using Eq. 11 (‚). (B) TheM of monovalent salts at physiological ionic strength (F). AChR (5 nM ACh sites) in 10 mM Hepes/250 mM salt was titrated
with concentrated Dns-C6-Cho as described in Materials and Methods. KD and Kapp values were determined from binding isotherms measured in the
presence and absence of 10 M proadifen, respectively. M was then calculated for the indicated salts from KD and Kapp values using Eq. 11. Nonspecific
binding was determined from parallel titrations that included 1 mM Carb.
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dues will be subject to electrostatic shielding by solvent ions
at higher ionic strengths that will diminish electrostatic
attraction between opposite charges and repulsion between
like charges. It is of interest to consider the possible loci for
charges that would move relatively to each other during the
conformational change. In principle, such charged groups
can reside anywhere on the conformational pathway in-
volved in desensitization, but two likely options are residues
near the ACh binding sites and residues in the pore. These
two regions are known to undergo structural changes that
cause changes in affinity for agonists and antagonists.
Structural models by Furois-Corbin and Pullman (1989)
of the M2 helix in the pore indicate a concerted separation
of the outer ring of negative charges (Imoto et al., 1988)
upon desensitization. This model was supported by the
labeling pattern of 3-trifluoromethyl-3-(m-[125I]iodophenyl)
diazirine (White and Cohen, 1992). This charge separation
should be stabilized by decreased ionic screening at low
ionic strength, a prediction that is consistent with our ob-
servations (Fig. 8). Alternatively, at the ACh binding sites,
several residues have been identified that may be involved
in charge-dependent conformational changes. Mutation of
residue Lys-34 affects agonist binding (Prince and Sine,
1996; Sine et al., 1995); however, in the presence of proa-
difen, which desensitizes the AChR, the effect of mutation
on binding was modest. Mutation of Asp-174 or the ho-
mologous  subunit amino acid, Asp-180, has larger ef-
fects on agonist affinity than on d-tubocurarine binding
(Martin et al., 1996). Because d-tubocurarine desensitizes
substantially less than agonists (Pedersen and Papineni,
1995), this observation is consistent with effects on the
conformational equilibrium rather than a direct interaction
with the ligand charge. Electrostatic interactions of these
residues with other nearby charges could result in the ionic
strength effects on conformational change that we observed.
These hypotheses can be tested by measuring M for AChRs
mutagenized at candidate residues.
Negative charges at the ACh binding sites
In addition to modulation of the conformational equilib-
rium, ions clearly affect binding through local effects at or
near the binding site itself. These were seen most clearly
when conformational equilibria were suppressed by main-
taining the AChR in the desensitized conformation in the
presence of proadifen. Addition of NaCl decreased binding
until concentrations of 200 mM, whereupon no further loss
of binding was observed (Figs. 4 and 5). This is inconsistent
with inhibition through a purely competitive mechanism
where Na
 binds to a site and sterically blocks the ACh
binding site, as illustrated in Fig. 9 A. Similar patterns of
inhibition were observed for Li
, K
, and Rb
, indicating
that they also do not directly compete for binding. In con-
trast, from electrophysiological measurements of associa-
tion rates of ACh for the mouse AChR, Akk and Auerbach
(1996) concluded that Na
, K
, and Cs
 bind directly to
the ACh binding sites. However, their observations tested
cations over a modest concentration range that may not have
excluded allosteric or other mechanisms. Our data preclude
direct, competitive binding of Na
 and K
 to the Torpedo
AChR, though not necessarily for Cs
.
FIGURE 8 A model for charge-rearrangement upon desensitization of
the AChR. Two cross-sectional views of the transmembrane region of the
AChR are shown with distinct placement of the M2 putative transmem-
brane -helices that correspond to the resting and desensitized conforma-
tions of the AChR.
FIGURE 9 Models for inhibition of ACh binding by cations. (A) Com-
petitive model; a negative site is located at the ACh site and binding of a
cation directly blocks the binding of agonist. (B) Pure electrostatic model;
negative charges are dispersed near the ACh site. Debye-Hu¨ckel-type
electrostatic screening of these charges results in decreased agonist affinity.
(C) Electrostatic plus steric interaction model: same as (B) with a charge
located at the edge of the ACh site, forming a negative subsite. Large
cations bind to the subsite, sterically destabilizing agonist binding to an
extent that depends on cation size.
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The noncompetitive nature of the cation effect on agonist
binding suggests that electrostatic screening of charges near
the ACh site was responsible for the change in agonist
binding affinities. However, different cations affected bind-
ing to different extents: clearly, there exists some cation
specificity. Thus, a model of pure Debye-Hu¨ckel-type elec-
trostatic screening of charges near the ACh site cannot
account for the effects of all the ions tested (illustrated in
Fig. 9 B).
One possible explanation for cation specificity is that a
negative subsite exists at the edge of the ACh binding site,
as illustrated in Fig. 9 C. Such a subsite would be close
enough to the bound agonist so that a bound cation will
interact with the agonist sterically, but without blocking
binding altogether. According to this model, larger cations
would generate greater destabilization. Thus, the rank order
of the extent of decrease in agonist binding affinity would
correlate with cation size, as we observed.
The effects of the smaller cations, Li
, Na
, and K
, on
agonist affinity were similar, suggesting that purely ionic
screening effects dominate the effects of small ions, rather
than the steric effect from the negative subsite, which ap-
pears more important for Rb
 and Cs
. If we interpret the
effects of small cations in terms of purely electrostatic
screening, then Debye-Hu¨ckel theory (Eq. 8) may be ap-
plied to extract values for the effective charge distribution
near the agonist binding sites. The ionic strength depen-
dence of the dissociation constant of the desensitized con-
formation, as defined by the presence of proadifen, was fit
to Eq. 8, and the result is displayed in Fig. 10. The best fit
of the data obtained from binding isotherms (E, dotted line),
at ionic strengths 0.5 M) gives the following values: zR 
8.1, r  1.9 nm, and K0  0.48 nM for the effective
charge at the binding site, the effective radius, and the
dissociation constant at zero ionic strength, respectively.
From fitting the data of single-concentration measurements
(F, solid line), zR  8.8, r  2.0 nm, and K0  0.39 nM.
Because Debye-Hu¨ckel theory is generally only valid for
dilute solutions, we also examined the data at ionic strength
	0.1 M, and obtained ZR  5.1, r  1.0 nm, and K0 
0.56 nM. Thus, about five to nine net negative charges with
an effective radius of 1 to 2 nm are distributed at or near the
ACh sites.
Stauffer and Karlin (1994) estimated two to three charges
at the ACh sites by measuring the rate of reaction of
variously charged methanethiosulfonates with Cys-192/
193. The difference between their conclusion and ours may
reflect the distinct techniques used or that the vicinity of
Cys-192/193 may differ from that of the binding site per
se. The methods we used for this analysis were similar to
those used by Nolte et al. (1980) to analyze the charge
distribution near the active site of acetylcholinesterase.
They found an effective charge of 6 to 9 that they
predicted were distributed in a broad area on the surface of
the protein. Nonetheless, their results were often interpreted
as evidence for a cluster of charges in close apposition to
ACh, acting as a countercharge or salt bridge (Quinn, 1987).
Later, the x-ray crystal structure showed the presence of
only one negative group in the active site and many nega-
tively charged groups dispersed over a large surface area
(Sussman et al., 1991). Likewise, our analysis is consistent
with a model of multiple negative charges dispersed near
the ACh binding site.
CONCLUSIONS
The AChR was found to be substantially desensitized at low
ionic strength. The fraction of desensitized AChR, which is
10–20% at high ionic strength, increases as the ionic
strength decreases through effects likely mediated by elec-
trostatic screening of charged residues that move relative to
each other during the conformational transition. Five to nine
negatively charged groups exist at or near the ACh sites in
the extracellular domains. The interactions between small
cations and the ACh sites are noncompetitive, whereas
larger ions may contribute to inhibition by direct binding
near the site.
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